Zillies Jan C, Zwiorek Klaus, Winter Gerhard, Coester Conrad
Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Butenandtstrasse 5, 81377 Munich, Germany.
Anal Chem. 2007 Jun 15;79(12):4574-80. doi: 10.1021/ac062135e. Epub 2007 May 17.
The PEGylation of colloidal drug carrier systems protects them from a rapid clearance from the blood stream and therefore prolongs their plasma half-lives. This fundamental concept is nowadays widely applied whereas the analytical description, i.e., the quantification of the PEGylation process, is still challenging due to the poor spectrophotometrical properties of PEG. The aim of this work is to quantify the PEGylation process of gelatin nanoparticles by utilizing the combination of asymmetrical flow field-flow fractionation (AF4) and refractive index (RI) detection and to demonstrate the potential of AF4 in the work with colloidal drug carrier systems. An AF4 separation mechanism of gelatin nanoparticles and PEG was developed without further sample preparation. After separation, the PEGylation could be directly quantified from the respective RI data and a threshold of a maximum amount of PEG that can be bound onto the surface of the nanoparticles could be determined. The PEGylation could be further visualized by atomic force microscopy (AFM). In sum, the presented results show the successful application of AF4 in the field of colloidal drug carrier systems, and in combination with AFM, both techniques can be stated as promising tools for the future analysis of colloidal drug carrier systems.
胶体药物载体系统的聚乙二醇化可保护它们免于从血流中快速清除,因此延长了它们的血浆半衰期。如今这一基本概念已被广泛应用,然而由于聚乙二醇(PEG)的分光光度特性较差,其分析描述,即聚乙二醇化过程的量化,仍然具有挑战性。这项工作的目的是通过结合不对称流场流分馏(AF4)和折射率(RI)检测来量化明胶纳米颗粒的聚乙二醇化过程,并证明AF4在胶体药物载体系统研究中的潜力。在无需进一步样品制备的情况下,建立了明胶纳米颗粒和PEG的AF4分离机制。分离后,可直接从各自的RI数据中量化聚乙二醇化,并确定可结合到纳米颗粒表面的PEG最大量阈值。聚乙二醇化还可通过原子力显微镜(AFM)进一步可视化。总之,所呈现的结果表明AF4在胶体药物载体系统领域的成功应用,并且与AFM相结合,这两种技术均可被视为未来胶体药物载体系统分析的有前景的工具。